regulation of respiration in one paragraph summary.

Reading File
Finding Sources
Reading File
Here is a concise one-paragraph summary of the regulation of respiration, drawn directly from Guyton and Hall:

Respiration is regulated by the respiratory center in the medulla and pons, which consists of three main groups: the dorsal respiratory group (DRG), the ventral respiratory group (VRG), and the pneumotaxic center. The DRG, located in the nucleus of the tractus solitarius (NTS), drives the basic inspiratory rhythm by generating a repetitive "ramp" signal to the diaphragm - starting weakly and building over ~2 seconds, then cutting off to allow passive expiration. The pre-Bötzinger complex, a region of the rostral VRG, acts as the core central pattern generator, containing pacemaker-like neurons that sustain this rhythmic output. The pneumotaxic center in the upper pons controls the rate of respiration by terminating the inspiratory ramp earlier when needed (increasing frequency) or later (slowing rate and deepening breaths). Superimposed on this neural rhythm is chemical regulation: central chemoreceptors in the medulla detect rising CO2 (via increased H⁺ in cerebrospinal fluid) and powerfully stimulate ventilation, while peripheral chemoreceptors in the carotid and aortic bodies respond to falling PO2, rising PCO2, and rising H⁺, relaying signals via the glossopharyngeal and vagus nerves to the NTS. Decreased arterial PO2 below ~60 mmHg markedly drives ventilation through peripheral chemoreceptors, whereas CO2/H⁺ changes are the dominant day-to-day stimuli. Additional inputs from lung stretch receptors (Hering-Breuer reflex), baroreceptors, and higher cortical centers (allowing voluntary override) fine-tune this integrated system to continuously match ventilation to metabolic demand.
(Guyton and Hall Textbook of Medical Physiology, pp. 531-540)

2. Read up on the hemoglobin oxygen dissociation curve & factors affecting the curve? create a simple summary for this

Finding Sources
Searching Images

hemoglobin oxygen dissociation curve factors affecting shift

This diagnostic image set displays two functional MR images (A and B) showing maternal-fetal units in a mouse model at embryonic days 14.5 and 17.5. The images feature overlaid color-coded AP50 maps, which represent fetal and placental oxygen-hemoglobin dissociation parameters. In both panels, the placenta and fetal liver are isolated as regions of interest. A vertical color bar on the right side indicates AP50 values scaled from 0 to 1.0, with cool colors (dark blue) representing lower values and warm colors (red/orange) representing higher values. Panel A (day 14.5) demonstrates a heterogeneous distribution of oxygenation parameters within the tissues, showing a mix of green, yellow, and blue pixels. Panel B (day 17.5) illustrates the progression of these physiological markers over time, with the placental AP50 values showing a significant spatial shift toward warmer colors, reflecting changes in oxygen transfer efficiency. These maps provide a non-invasive visual method for studying fetal oxygenation and placental function during gestation.

This diagnostic image set displays two functional MR images (A and B) showing maternal-fetal units in a mouse model at embryonic days 14.5 and 17.5. The images feature overlaid color-coded AP50 maps, which represent fetal and placental oxygen-hemoglobin dissociation parameters. In both panels, the placenta and fetal liver are isolated as regions of interest. A vertical color bar on the right side indicates AP50 values scaled from 0 to 1.0, with cool colors (dark blue) representing lower values and warm colors (red/orange) representing higher values. Panel A (day 14.5) demonstrates a heterogeneous distribution of oxygenation parameters within the tissues, showing a mix of green, yellow, and blue pixels. Panel B (day 17.5) illustrates the progression of these physiological markers over time, with the placental AP50 values showing a significant spatial shift toward warmer colors, reflecting changes in oxygen transfer efficiency. These maps provide a non-invasive visual method for studying fetal oxygenation and placental function during gestation.

Summary : This figure illustrates the relationship between hemoglobin (Hb) level and oxygen delivery in individuals with sickle cell disease (SCD), highlighting the optimal Hb range for oxygen transport in SCD compared to normal individuals.

line plot:
# Title & Axes :
  • No explicit title on the plot, but the context is "Relationship between hemoglobin level and oxygen delivery in individuals with SCD."
  • X-axis: "Hemoglobin" (units not specified, but contextually g/dL).
  • Y-axis: "Oxygen delivery" (units not specified).
  • X-axis tick labels: 10, 15, 20.
  • Y-axis: No tick labels, only qualitative trend.

# Data Points & Series :
  • Single red curve showing oxygen delivery as a function of hemoglobin level.
  • The curve rises from Hb = 10, peaks near Hb = 14–16, then declines toward Hb = 20.
  • Arrow and annotation for "Sickle Cell Anemia Hb_max ~10–11" indicating the optimal Hb range for SCD.
  • Dashed vertical line at "Normal Hb_max ~14–16" indicating the optimal Hb range for normal individuals.

# Design Encodings :
  • Red solid line for the main curve.
  • Yellow arrow highlighting the SCD optimal Hb range.
  • Dashed vertical line for normal Hb_max.
  • Text annotations for "Sickle Cell Anemia Hb_max ~10–11" and "Normal Hb_max ~14–16".

# Distribution & Trends :
  • The curve is unimodal, peaking at intermediate Hb levels.
  • Oxygen delivery increases with Hb up to a point, then decreases at higher Hb levels.
  • The optimal Hb for SCD is lower (~10–11 g/dL) than for normal individuals (~14–16 g/dL).

# Analysis :
  • The figure visually demonstrates that the maximal oxygen delivery in SCD occurs at a lower hemoglobin level than in normal individuals, due to altered red cell viscosity and oxygen transport in SCD.
  • Increasing Hb above the SCD optimal range may decrease oxygen delivery, while lowering Hb to the optimal range can improve oxygen transport.
  • The curve supports clinical recommendations for transfusion targets in SCD patients to avoid excessive Hb levels that could impair oxygen delivery.

Summary : This figure illustrates the relationship between hemoglobin (Hb) level and oxygen delivery in individuals with sickle cell disease (SCD), highlighting the optimal Hb range for oxygen transport in SCD compared to normal individuals. line plot: # Title & Axes : • No explicit title on the plot, but the context is "Relationship between hemoglobin level and oxygen delivery in individuals with SCD." • X-axis: "Hemoglobin" (units not specified, but contextually g/dL). • Y-axis: "Oxygen delivery" (units not specified). • X-axis tick labels: 10, 15, 20. • Y-axis: No tick labels, only qualitative trend. # Data Points & Series : • Single red curve showing oxygen delivery as a function of hemoglobin level. • The curve rises from Hb = 10, peaks near Hb = 14–16, then declines toward Hb = 20. • Arrow and annotation for "Sickle Cell Anemia Hb_max ~10–11" indicating the optimal Hb range for SCD. • Dashed vertical line at "Normal Hb_max ~14–16" indicating the optimal Hb range for normal individuals. # Design Encodings : • Red solid line for the main curve. • Yellow arrow highlighting the SCD optimal Hb range. • Dashed vertical line for normal Hb_max. • Text annotations for "Sickle Cell Anemia Hb_max ~10–11" and "Normal Hb_max ~14–16". # Distribution & Trends : • The curve is unimodal, peaking at intermediate Hb levels. • Oxygen delivery increases with Hb up to a point, then decreases at higher Hb levels. • The optimal Hb for SCD is lower (~10–11 g/dL) than for normal individuals (~14–16 g/dL). # Analysis : • The figure visually demonstrates that the maximal oxygen delivery in SCD occurs at a lower hemoglobin level than in normal individuals, due to altered red cell viscosity and oxygen transport in SCD. • Increasing Hb above the SCD optimal range may decrease oxygen delivery, while lowering Hb to the optimal range can improve oxygen transport. • The curve supports clinical recommendations for transfusion targets in SCD patients to avoid excessive Hb levels that could impair oxygen delivery.

This composite diagnostic image displays Multispectral Optoacoustic Tomography (MSOT) scans of a lung xenograft tumor model in a mouse. The panel compares a control group (top row) with a CA4P-treated group (bottom row) at four time points: 0h, 1h, 3h, and 24h. The pseudocolor overlay represents hemoglobin oxygen saturation (%SO2) on a scale from 0% (dark blue/black) to 80% (bright red). Red indicates high oxyhemoglobin levels, while blue represents deoxyhemoglobin or blood-deficient areas. In the control group, the tumor exhibits persistent heterogeneous oxygenation (mixed red and blue) throughout the 24-hour period. In the CA4P group, the tumor undergoes a dramatic shift from high baseline oxygenation at 0h to a predominantly blue signal at 1h, 3h, and 24h. This visual transition demonstrates the pharmacodynamic effect of Combretastatin A-4 phosphate (CA4P) as a vascular disrupting agent (VDA), illustrating immediate and sustained vascular shutdown, resulting in acute tumor hypoxia and reduced perfusion. Scale bars represent 5 mm.

This composite diagnostic image displays Multispectral Optoacoustic Tomography (MSOT) scans of a lung xenograft tumor model in a mouse. The panel compares a control group (top row) with a CA4P-treated group (bottom row) at four time points: 0h, 1h, 3h, and 24h. The pseudocolor overlay represents hemoglobin oxygen saturation (%SO2) on a scale from 0% (dark blue/black) to 80% (bright red). Red indicates high oxyhemoglobin levels, while blue represents deoxyhemoglobin or blood-deficient areas. In the control group, the tumor exhibits persistent heterogeneous oxygenation (mixed red and blue) throughout the 24-hour period. In the CA4P group, the tumor undergoes a dramatic shift from high baseline oxygenation at 0h to a predominantly blue signal at 1h, 3h, and 24h. This visual transition demonstrates the pharmacodynamic effect of Combretastatin A-4 phosphate (CA4P) as a vascular disrupting agent (VDA), illustrating immediate and sustained vascular shutdown, resulting in acute tumor hypoxia and reduced perfusion. Scale bars represent 5 mm.

Finding Sources
Reading File
Reading File
Loading Image
Loading Image
Both diagrams retrieved directly from Guyton & Hall. Here is the complete summary:

Hemoglobin-Oxygen Dissociation Curve

What Is It?

The oxygen-hemoglobin dissociation curve plots hemoglobin saturation (%) against blood PO2 (mmHg). It has a characteristic S-shape (sigmoidal), which is not an accident - it reflects the cooperative binding of O2 to hemoglobin's four heme sites (each O2 bound makes the next one easier to bind).
O2-Hemoglobin Dissociation Curve - Guyton & Hall Fig 41.9

Key Reference Points

LocationPO2Hb SaturationO2 Content
Normal arterial blood (lungs)~95 mmHg97%~19.4 mL/100 mL
Normal venous blood (tissues)~40 mmHg75%~14.4 mL/100 mL
Venous blood in heavy exercise~15 mmHg~35%~4.4 mL/100 mL
  • Under resting conditions, ~5 mL O2 is delivered to tissues per 100 mL blood
  • During strenuous exercise, this rises to ~15 mL O2 per 100 mL blood (3x normal)
The flat upper portion (above ~70 mmHg) means Hb stays highly saturated even if PO2 drops somewhat - a safety buffer in the lungs. The steep lower portion (below ~60 mmHg) means small drops in tissue PO2 cause large O2 unloading - ideal for tissue delivery.

The P50

P50 is the PO2 at which hemoglobin is 50% saturated - normally ~26 mmHg. It is used as a reference point to describe curve shifts.

Factors Affecting the Curve

Shift of the O2-Hemoglobin Dissociation Curve - Guyton & Hall Fig 41.10

RIGHT SHIFT = Hb releases O2 more readily (good for tissues)

P50 increases. Less O2 held by Hb at any given PO2.
FactorPhysiological Context
↑ H⁺ (↓ pH)Acidosis, exercising muscle
↑ CO2 (Bohr effect)Tissues produce CO2
↑ TemperatureActive/exercising muscle
↑ 2,3-BPGChronic hypoxia, anemia, high altitude
Bohr Effect: When blood reaches the tissues, rising CO2 lowers pH, shifting the curve right - Hb dumps O2 exactly where it's needed most. In the lungs, CO2 offloads, pH rises, curve shifts left, and Hb loads O2 again.
2,3-BPG (bisphosphoglycerate): A byproduct of RBC glycolysis. Binds to deoxyHb and stabilizes it, reducing O2 affinity. During prolonged hypoxia, BPG increases and allows O2 release at a tissue PO2 as much as 10 mmHg higher than normal - an important adaptation mechanism.

LEFT SHIFT = Hb holds O2 more tightly (good for lungs, bad for tissues)

P50 decreases. More O2 is loaded at a given PO2 but less is released.
FactorPhysiological Context
↓ H⁺ (↑ pH)Alkalosis
↓ CO2Hyperventilation, lungs
↓ TemperatureHypothermia
↓ 2,3-BPGStored blood, rare enzyme deficiencies
Fetal Hb (HbF)Has higher O2 affinity to steal O2 from mother
Carbon monoxide (CO)CO binds Hb ~250x stronger than O2; left-shifts remaining sites

Simple Memory Rule

"CADET, face RIGHT" - CO2 ↑, Acid ↑, DPG (2,3-BPG) ↑, Exercise, Temperature ↑ → Right shift
(Guyton and Hall Textbook of Medical Physiology, pp. 523-527)

pemonia in detailed summary

Finding Sources
Searching Images

pneumonia chest x-ray consolidation lobar

This diagnostic image is an anteroposterior (AP) chest X-ray of a pediatric patient demonstrating classic findings of lobar pneumonia. A prominent, dense, and homogenous opacification is localized to the right upper lobe, consistent with pulmonary consolidation. The opacification has a well-defined inferior border along the horizontal fissure, indicated by a red arrow, which is a hallmark of lobar involvement. Normal lung markings in this region are obscured, while the left lung field appears relatively clear and well-aerated. The cardiac silhouette and mediastinal structures appear within normal limits for this projection, with no significant shift or widening. The diaphragm and costophrenic angles are visible, though the right side is partially obscured by the adjacent consolidation. This image serves as an educational example of bacterial pneumonia presentation in a clinical setting, highlighting the radiographic appearance of alveolar space filling.

This diagnostic image is an anteroposterior (AP) chest X-ray of a pediatric patient demonstrating classic findings of lobar pneumonia. A prominent, dense, and homogenous opacification is localized to the right upper lobe, consistent with pulmonary consolidation. The opacification has a well-defined inferior border along the horizontal fissure, indicated by a red arrow, which is a hallmark of lobar involvement. Normal lung markings in this region are obscured, while the left lung field appears relatively clear and well-aerated. The cardiac silhouette and mediastinal structures appear within normal limits for this projection, with no significant shift or widening. The diaphragm and costophrenic angles are visible, though the right side is partially obscured by the adjacent consolidation. This image serves as an educational example of bacterial pneumonia presentation in a clinical setting, highlighting the radiographic appearance of alveolar space filling.

Multi-modal diagnostic imaging series illustrating community-acquired lobar pneumonia in a 30-year-old patient. (a) Posterior-anterior chest X-ray shows a clear area of consolidation in the left upper lobe. (b) B-mode lung ultrasound (LUS) reveals a complex, hypoechoic consolidation containing numerous hyperechoic punctate and linear structures, characteristic of a marked air bronchogram. (c-e) Contrast-enhanced ultrasound (CEUS) time-series demonstrates perfusion dynamics: (c) at 13 seconds, there is homogeneous pulmonary arterial enhancement; (d) by 1 minute, significant early washout occurs; (e) by 2 minutes, the washout is more pronounced. This specific CEUS pattern of rapid washout is indicative of pulmonary arterial vasoconstriction, often associated with the Euler–Liljestrand mechanism in response to local hypoxia in consolidated lung tissue. The series serves as an educational example of how multi-phase CEUS can supplement B-mode ultrasound and radiography in characterizing the hemodynamic response of pulmonary parenchyma during inflammatory processes.

Multi-modal diagnostic imaging series illustrating community-acquired lobar pneumonia in a 30-year-old patient. (a) Posterior-anterior chest X-ray shows a clear area of consolidation in the left upper lobe. (b) B-mode lung ultrasound (LUS) reveals a complex, hypoechoic consolidation containing numerous hyperechoic punctate and linear structures, characteristic of a marked air bronchogram. (c-e) Contrast-enhanced ultrasound (CEUS) time-series demonstrates perfusion dynamics: (c) at 13 seconds, there is homogeneous pulmonary arterial enhancement; (d) by 1 minute, significant early washout occurs; (e) by 2 minutes, the washout is more pronounced. This specific CEUS pattern of rapid washout is indicative of pulmonary arterial vasoconstriction, often associated with the Euler–Liljestrand mechanism in response to local hypoxia in consolidated lung tissue. The series serves as an educational example of how multi-phase CEUS can supplement B-mode ultrasound and radiography in characterizing the hemodynamic response of pulmonary parenchyma during inflammatory processes.

A frontal (anteroposterior) chest X-ray demonstrating clinical signs of pneumonia. A prominent blue arrow indicates a large area of increased opacity in the right lower lung field, suggestive of lobar consolidation or a dense pulmonary infiltrate. The opacity is heterogeneous with ill-defined borders, blending into the surrounding parenchyma. Beyond the focal area, there are diffuse bilateral reticulonodular interstitial markings, more pronounced in the mid and lower lung zones. The right costophrenic angle is relatively sharp, while the left shows mild blunting. Several medical devices are present: multiple radiopaque ECG leads/electrodes are positioned on the upper chest and shoulders, and a radiopaque enteric tube (nasogastric or feeding tube) is visible traversing the mediastinum toward the stomach. The image illustrates typical radiological findings of an infectious process in an acute clinical setting, highlighting focal consolidation against a background of generalized pulmonary congestion or inflammation.

A frontal (anteroposterior) chest X-ray demonstrating clinical signs of pneumonia. A prominent blue arrow indicates a large area of increased opacity in the right lower lung field, suggestive of lobar consolidation or a dense pulmonary infiltrate. The opacity is heterogeneous with ill-defined borders, blending into the surrounding parenchyma. Beyond the focal area, there are diffuse bilateral reticulonodular interstitial markings, more pronounced in the mid and lower lung zones. The right costophrenic angle is relatively sharp, while the left shows mild blunting. Several medical devices are present: multiple radiopaque ECG leads/electrodes are positioned on the upper chest and shoulders, and a radiopaque enteric tube (nasogastric or feeding tube) is visible traversing the mediastinum toward the stomach. The image illustrates typical radiological findings of an infectious process in an acute clinical setting, highlighting focal consolidation against a background of generalized pulmonary congestion or inflammation.

Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive material from multiple authoritative sources. Here is the detailed summary:

Pneumonia - Detailed Summary

Definition

Pneumonia is an infection of the lung parenchyma that leads to consolidation of the normally air-filled alveoli. It can be caused by bacteria, viruses, mycoplasma, mycobacteria, and fungi. It affects all age groups and is one of the leading causes of infection-related hospitalization worldwide, accounting for over 1 million hospitalizations per year in the US with an in-hospital mortality of ~3.3%.

Classification

TypeDefinitionKey Pathogens
CAP (Community-Acquired)Present before or within 48h of admissionS. pneumoniae, Mycoplasma, Chlamydia, Legionella, H. influenzae, respiratory viruses
HAP (Hospital-Acquired)Develops ≥2 days after hospital admissionS. aureus (incl. MRSA), Pseudomonas, gram-negative enteric bacilli, Acinetobacter
VAP (Ventilator-Associated)Occurs ≥3 days after mechanical ventilation onsetSame as HAP; Pseudomonas, MRSA, Acinetobacter (resistant strains common)
AspirationCaused by inhalation of oropharyngeal/gastric contentsAnaerobes (Peptostreptococcus, Bacteroides), gram-negatives
OpportunisticIn immunocompromised hostsPCP (Pneumocystis jirovecii), Cryptococcus, Aspergillus, atypical mycobacteria

Common Pathogens by Clinical Pattern

Classic / Typical Pneumonia (abrupt onset, high fever, productive cough, lobar consolidation):
  • Streptococcus pneumoniae - most common bacterial CAP
  • Staphylococcus aureus - aggressive, post-viral or skin infection
  • Klebsiella pneumoniae - alcoholics, upper lobe "currant jelly" sputum
  • H. influenzae - COPD patients, elderly
Atypical Pneumonia (gradual onset, low-grade fever, dry cough, bilateral patchy infiltrates):
  • Mycoplasma pneumoniae - young adults ("walking pneumonia")
  • Chlamydia pneumoniae - similar to Mycoplasma
  • Legionella pneumophila - contaminated water/AC systems, GI symptoms, hyponatremia
  • Respiratory viruses (influenza, RSV, SARS-CoV-2, parainfluenza)

Clinical Presentation

FeatureTypical (Bacterial)Atypical
OnsetAbruptGradual
FeverHigh-grade, rigorsLow-grade
CoughProductive, purulentDry, nonproductive
AppearanceAcutely ill, toxicLess toxic ("walks in")
WBC>15,000, neutrophil predominanceNormal or mildly elevated
Common symptoms across types:
  • Cough (productive or dry), fever, dyspnea, pleuritic chest pain, malaise
  • Tachypnea, tachycardia
Examination findings (after consolidation):
  • Decreased breath sounds over affected area
  • Dullness to percussion
  • Egophony ("E to A" change)
  • Bronchial breathing, crackles
In children: Tachypnea disproportionate to fever is often the earliest clue. Viral pneumonia = less toxic, wheezing. Bacterial = high fever, chills, dyspnea, intercostal retractions.

Diagnosis

Chest X-Ray

  • Bacterial (lobar): Dense homogeneous lobar consolidation, air bronchograms
  • Viral/Atypical: Patchy or streaky bilateral interstitial infiltrates, hyperinflation
  • Note: CXR findings can lag behind clinical presentation by 1-2 days and may be normal on day 1
  • Complications visible on CXR: parapneumonic effusion, empyema, abscess, pneumatocele
Lobar pneumonia - right upper lobe consolidation on CXR

Laboratory Tests

TestUse
CBCLeukocytosis with neutrophilia (bacterial); normal/mild elevation (atypical/viral)
Sputum Gram stain + cultureLow yield but identifies dominant organism
Blood cultures2 sets before antibiotics in severe/hospitalized cases
Urinary antigenLegionella (sensitive and specific); S. pneumoniae
Cold agglutininsMycoplasma (positive in ~50%)
AFB smear/cultureSuspected TB
ProcalcitoninHelps distinguish bacterial from viral; guides antibiotic de-escalation
ABG / pulse oximetryAssess oxygenation severity
BAL/bronchoscopyReserved for immunocompromised, VAP, or diagnostic uncertainty

Severity Assessment

CURB-65 Score (1 point each)

CriterionThreshold
ConfusionNew disorientation to person/place/time
UremiaBUN >20 mg/dL
Respiratory rate≥30 breaths/min
Blood pressureSystolic <90 or diastolic ≤60 mmHg
Age≥65 years
  • Score 0-1: Low risk - outpatient treatment
  • Score 2: Intermediate - consider short admission or close follow-up
  • Score ≥3: High risk - hospitalize; score ≥4 or 5 consider ICU

ICU Admission Criteria (IDSA/ATS)

Admit to ICU if: septic shock requiring vasopressors, mechanical ventilation needed, OR ≥3 minor criteria:
  • RR ≥30, PaO2/FiO2 ≤250, multilobar infiltrates, confusion, BUN ≥20, WBC <4000, platelets <100,000, temp <36°C, hypotension requiring aggressive fluids

Treatment

CAP - Outpatient

PatientAntibiotic
Previously healthy, no recent antibioticsAzithromycin or Clarithromycin (macrolide) OR Doxycycline
Comorbidities (DM, heart/lung/liver/renal disease, alcoholism, cancer, immunosuppression) OR antibiotic use in last 3 monthsRespiratory fluoroquinolone (moxifloxacin, levofloxacin) OR Beta-lactam + macrolide combo

CAP - Hospitalized (Non-ICU)

  • Beta-lactam (ampicillin-sulbactam, ceftriaxone) + macrolide OR
  • Respiratory fluoroquinolone alone

CAP - ICU / Severe

  • Beta-lactam (ceftriaxone or cefotaxime) + azithromycin or fluoroquinolone
  • If Pseudomonas risk: antipseudomonal beta-lactam (piperacillin-tazobactam)
  • If MRSA risk: add vancomycin or linezolid

HAP / VAP

  • Empiric: antipseudomonal beta-lactam (piperacillin-tazobactam, cefepime, meropenem) ± vancomycin/linezolid (if MRSA risk)
  • De-escalate based on culture results
  • Treatment duration: typically 7 days for VAP (may vary by organism)

Duration

  • Minimum 5 days for CAP; at least 48-72 hours after last fever/clinical instability
  • Reassess at 72 hours - if no improvement, broaden coverage or reconsider diagnosis

Complications

  • Parapneumonic effusion / Empyema - requires drainage if loculated
  • Lung abscess - prolonged antibiotics (anaerobes, S. aureus); CT-guided or surgical drainage
  • Bacteremia / Sepsis - especially with S. pneumoniae
  • Respiratory failure / ARDS - ICU-level support, mechanical ventilation
  • Pneumatocele - air-filled cysts, especially in S. aureus pneumonia in children

Prevention

  • Influenza vaccine: Annually for everyone >6 months; especially those >50, chronic lung disease, diabetes, immunosuppression
  • Pneumococcal vaccine (PCV13/PPSV23): All children <5 years; all adults ≥65; younger adults with chronic conditions or asplenia. Revaccinate with PPSV23 after 10 years if first dose given before age 65
  • Smoking cessation, good oral hygiene, and head-of-bed elevation (for VAP prevention)
(Textbook of Family Medicine 9e, pp. 321-322; Symptom to Diagnosis 4e; Current Surgical Therapy 14e)

one paragraph summaryy

Here is pneumonia in one paragraph:

Pneumonia is an infection of the lung parenchyma causing alveolar consolidation, and can be classified as community-acquired (CAP), hospital-acquired (HAP), or ventilator-associated (VAP). The most common bacterial cause of CAP is Streptococcus pneumoniae, presenting with abrupt-onset high fever, rigors, productive cough, pleuritic chest pain, and lobar consolidation on chest X-ray, while atypical organisms (Mycoplasma, Chlamydia, Legionella) cause a more gradual, "walking" illness with dry cough and bilateral patchy infiltrates. Diagnosis is primarily clinical and radiological, supported by CBC (leukocytosis with neutrophilia in bacterial pneumonia), sputum Gram stain and culture, blood cultures, and urinary antigen testing for Legionella and S. pneumoniae. Severity is stratified using the CURB-65 score (Confusion, Uremia, Respiratory rate ≥30, BP <90/60, Age ≥65) - scores 0-1 allow outpatient treatment, score 2 warrants hospital admission, and score ≥3 may require ICU. Treatment of mild outpatient CAP uses a macrolide (azithromycin) or doxycycline; patients with comorbidities or hospitalized patients receive a beta-lactam + macrolide or a respiratory fluoroquinolone; severe or ICU-level CAP requires combination beta-lactam + macrolide/fluoroquinolone, with vancomycin or linezolid added if MRSA is suspected. HAP and VAP require broader empiric coverage targeting Pseudomonas, MRSA, and resistant gram-negatives with antipseudomonal beta-lactams ± vancomycin, de-escalated based on cultures. Prevention relies on annual influenza vaccination and pneumococcal vaccination (PCV13/PPSV23) for high-risk groups and all adults ≥65 years.

pulmonary embolism

Finding Sources
Searching Images

pulmonary embolism CT angiography saddle embolus

This diagnostic axial CT angiography (CTA) scan of the chest reveals a classic saddle pulmonary embolism. The primary visual finding is a large, low-attenuation filling defect centrally located at the bifurcation of the main pulmonary artery. This thrombus straddles the carina and extends into both the right and left pulmonary arteries. Two red arrows indicate the specific sites where the hypodense embolus obstructs the contrast-enhanced pulmonary vasculature. The surrounding mediastinal structures, including the ascending aorta and the superior vena cava, are visible and show normal contrast enhancement. This imaging modality is the gold standard for diagnosing acute pulmonary embolism, and the 'saddle' configuration demonstrated here indicates a massive or submassive embolic event with high clinical significance for hemodynamic instability.

This diagnostic axial CT angiography (CTA) scan of the chest reveals a classic saddle pulmonary embolism. The primary visual finding is a large, low-attenuation filling defect centrally located at the bifurcation of the main pulmonary artery. This thrombus straddles the carina and extends into both the right and left pulmonary arteries. Two red arrows indicate the specific sites where the hypodense embolus obstructs the contrast-enhanced pulmonary vasculature. The surrounding mediastinal structures, including the ascending aorta and the superior vena cava, are visible and show normal contrast enhancement. This imaging modality is the gold standard for diagnosing acute pulmonary embolism, and the 'saddle' configuration demonstrated here indicates a massive or submassive embolic event with high clinical significance for hemodynamic instability.

This diagnostic image is an axial cut from a CT Pulmonary Angiography (CTPA) demonstrating extensive pulmonary embolism. The primary visual finding is a large, low-attenuation filling defect appearing as a 'saddle embolus' at the bifurcation of the main pulmonary artery, extending into both the right and left main pulmonary arteries (indicated by red arrows). The central filling defects are characterized by absent or significantly reduced contrast enhancement within the vessel lumens, which are otherwise surrounded by hyperdense contrast material. Additional thromboembolic material is visible in the lobar and segmental branches bilaterally. The main pulmonary artery shows evidence of distension secondary to the large obstructive clot burden. This image serves as a classic clinical example of acute, high-burden pulmonary embolism in a patient with risk factors such as prolonged immobility, illustrating the critical role of CTPA in diagnosing life-threatening vascular obstructions.

This diagnostic image is an axial cut from a CT Pulmonary Angiography (CTPA) demonstrating extensive pulmonary embolism. The primary visual finding is a large, low-attenuation filling defect appearing as a 'saddle embolus' at the bifurcation of the main pulmonary artery, extending into both the right and left main pulmonary arteries (indicated by red arrows). The central filling defects are characterized by absent or significantly reduced contrast enhancement within the vessel lumens, which are otherwise surrounded by hyperdense contrast material. Additional thromboembolic material is visible in the lobar and segmental branches bilaterally. The main pulmonary artery shows evidence of distension secondary to the large obstructive clot burden. This image serves as a classic clinical example of acute, high-burden pulmonary embolism in a patient with risk factors such as prolonged immobility, illustrating the critical role of CTPA in diagnosing life-threatening vascular obstructions.

**Imaging Modality:** Contrast-enhanced Computed Tomography (CT) of the chest, specifically a CT Pulmonary Angiography (CTPA) protocol.

**Anatomical Region:** Axial section of the thorax at the level of the pulmonary artery bifurcation.

**Observed Pathology:** Large, bilateral pulmonary embolism. A prominent "saddle" embolus is visible, characterized by low-attenuation (hypodense) filling defects within the lumen of the main pulmonary artery, extending into both the right and left main pulmonary arteries.

**Characteristic Visual Features:**
*   **Filling Defects:** Central non-opacified areas surrounded by radiopaque contrast media, creating the classic "Polo Mint" sign in cross-section or "railway track" sign in longitudinal views.
*   **Vascular Anatomy:** The pulmonary trunk appears dilated.
*   **Surrounding Structures:** The ascending and descending aorta, superior vena cava, and vertebral body are visible and unremarkable in this single slice. Metal streak artifacts are present anteriorly from sternal wires, suggesting prior cardiac surgery.

**Key Diagnostic Features:** The presence of a large, centrally located thrombus straddling the bifurcation of the pulmonary trunk (saddle embolus) is the pathognomonic finding for acute major pulmonary embolism.

**Imaging Modality:** Contrast-enhanced Computed Tomography (CT) of the chest, specifically a CT Pulmonary Angiography (CTPA) protocol. **Anatomical Region:** Axial section of the thorax at the level of the pulmonary artery bifurcation. **Observed Pathology:** Large, bilateral pulmonary embolism. A prominent "saddle" embolus is visible, characterized by low-attenuation (hypodense) filling defects within the lumen of the main pulmonary artery, extending into both the right and left main pulmonary arteries. **Characteristic Visual Features:** * **Filling Defects:** Central non-opacified areas surrounded by radiopaque contrast media, creating the classic "Polo Mint" sign in cross-section or "railway track" sign in longitudinal views. * **Vascular Anatomy:** The pulmonary trunk appears dilated. * **Surrounding Structures:** The ascending and descending aorta, superior vena cava, and vertebral body are visible and unremarkable in this single slice. Metal streak artifacts are present anteriorly from sternal wires, suggesting prior cardiac surgery. **Key Diagnostic Features:** The presence of a large, centrally located thrombus straddling the bifurcation of the pulmonary trunk (saddle embolus) is the pathognomonic finding for acute major pulmonary embolism.

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Excellent - I now have comprehensive material from Rosen's Emergency Medicine and the Textbook of Family Medicine. Here is the full detailed summary:

Pulmonary Embolism (PE) - Detailed Summary

Definition & Pathophysiology

Pulmonary embolism is the obstruction of pulmonary arteries by thrombus (most commonly), or rarely by fat, air, amniotic fluid, or tumor. As described by Virchow's triad, clot forms due to: hypercoagulability + venous stasis + vascular endothelial injury. Two thirds of emboli reach both lungs and lodge in large or intermediate pulmonary arteries, most often in the lower lobes. Obstruction causes:
  • V/Q mismatch (dead space ventilation) → hypoxemia
  • Pulmonary hypertension → acute right ventricular (RV) strain and failure
  • Decreased LV filling (septal shift) → reduced cardiac output → shock
  • Approximately 25% of sudden cardiac deaths are attributable to PE

Risk Factors (Virchow's Triad)

CategoryExamples
HypercoagulabilityCancer, pregnancy, oral contraceptives/estrogen, antiphospholipid syndrome, Factor V Leiden, Protein C/S deficiency, antithrombin III deficiency, prothrombin G20210A
StasisProlonged immobilization, long-haul air travel, hospitalization, heart failure, stroke
Vascular injuryMajor surgery (especially hip/pelvic), trauma, burns
OtherPrior DVT/PE (highest risk), obesity, smoking, age >35

Classification by Haemodynamic Severity

TypeDefinitionMortality
Massive PESustained hypotension (SBP <90 mmHg), shock, cardiac arrestVery high (>50%)
Submassive PENormotensive but with RV dysfunction on echo/CT or elevated troponin/BNPIntermediate (~3-15%)
Low-risk PENormotensive, normal RV function, normal biomarkersLow (<1%)

Clinical Presentation

Symptoms (nonspecific - can mimic almost any cardiothoracic condition):
  • Dyspnea - most common (75-80%), may be sudden or gradual, at rest or exertional
  • Pleuritic chest pain - sharp, worse on inspiration; indicates peripheral PE with pulmonary infarction (~20%)
  • Hemoptysis - suggests pulmonary infarction
  • Syncope - uncommon (<5%) but important; indicates massive PE with haemodynamic compromise
  • Unilateral leg swelling/tenderness - suggests underlying DVT (<30%)
Note: ~25% of patients have no dyspnea; ~33% have no chest pain. PE is a great mimicker.
Vital Signs:
  • Tachycardia - most common abnormality (~50%); alone the single strongest predictor of more severe PE
  • Tachypnoea - >20 breaths/min in ~50%
  • Hypotension (SBP <90) - only 10% but carries 4-fold increase in mortality
  • Hypoxemia (SpO2 <95%) - present in ~50%; normal SpO2 does NOT rule out PE
  • Shock index (HR > SBP) suggests impending haemodynamic collapse
Physical Exam:
  • Often normal
  • Unilateral leg swelling/edema/deep vein tenderness → DVT evidence (most specific finding for PE)
  • Loud P2, RV heave, elevated JVP (in massive PE with RV failure)
  • Localized rales over infarcted lung

Diagnosis

Step 1 - Estimate Pretest Probability

Wells Score for PE:
CriterionPoints
Clinical signs/symptoms of DVT3
PE more likely than alternative diagnosis3
Heart rate >100 bpm1.5
Immobilization/surgery in past 4 weeks1.5
Prior DVT or PE1.5
Hemoptysis1
Malignancy (on treatment or within 6 months)1
  • Score ≤4: Low/intermediate probability → D-dimer first
  • Score >4: High probability → proceed directly to CTPA

Step 2 - D-Dimer

  • Quantitative ELISA D-dimer <500 μg/L in low/intermediate pretest probability → rules out PE (high sensitivity ~97%)
  • D-dimer is not useful in high-probability patients or as a confirmatory test (low specificity - elevated in many conditions: surgery, infection, pregnancy, cancer)

Step 3 - Imaging

CTPA (CT Pulmonary Angiography) - gold standard:
  • Shows filling defects in pulmonary arteries
  • "Saddle embolus" at the main pulmonary artery bifurcation = massive PE
Saddle pulmonary embolism on CTPA - bilateral filling defects at pulmonary artery bifurcation
V/Q Scan: Used when CTPA is contraindicated (renal failure, contrast allergy, pregnancy to minimize radiation)
Other Investigations:
TestFinding in PE
ECGTachycardia (most common); S1Q3T3 pattern; T-wave inversion V1-V4; RBBB (all indicate acute cor pulmonale)
CXROften normal; Hampton's hump (peripheral wedge-shaped infarct); Westermark sign (oligaemia distal to embolus); elevated hemidiaphragm
TroponinElevated → myocardial injury from RV strain → higher mortality
BNP/NT-proBNPElevated → RV myocyte distension → worse prognosis
ABGHypoxemia, hypocapnia (tachypnoea-driven), elevated A-a gradient
EchoRV dilation, hypokinesis, McConnell's sign (apical sparing) - used in haemodynamic instability
Leg Doppler USConfirms DVT source

Treatment

By Severity

Massive PE (haemodynamically unstable):
  • Immediate systemic thrombolysis - alteplase 100 mg IV over 2 hours (survival benefit proven in haemodynamically unstable patients)
  • If thrombolysis contraindicated → surgical embolectomy or catheter-directed thrombolysis
  • Supportive: vasopressors (norepinephrine), mechanical ventilation if needed
  • Anticoagulate with IV unfractionated heparin (UFH) after thrombolytics
Submassive PE (normotensive, RV dysfunction):
  • Anticoagulation with LMWH (enoxaparin) or UFH - LMWH preferred (at least as effective, fewer bleeding complications, subcutaneous)
  • Consider thrombolysis if deteriorating despite anticoagulation
  • Close monitoring for haemodynamic decompensation
Low-Risk PE (normotensive, no RV dysfunction):
  • Anticoagulation alone - LMWH or direct oral anticoagulants (DOACs: rivaroxaban, apixaban)
  • Consider outpatient treatment for selected low-risk patients (HESTIA criteria / PESI score)

Long-Term Anticoagulation

ScenarioDuration
First episode, provoked (reversible risk factor)3 months
First episode, unprovoked3-6 months (consider indefinite)
Cancer-associated VTEIndefinitely (while cancer active)
Recurrent PE or hypercoagulabilityLifetime
Drug optionsWarfarin (INR 2-3), Rivaroxaban, Apixaban, Dabigatran, Edoxaban
IVC Filter: Reserved for patients with PE + absolute contraindication to anticoagulation, or recurrent PE despite therapeutic anticoagulation.

Prevention

  • Mechanical: Early mobilisation, compression stockings, intermittent pneumatic compression
  • Pharmacological: Low-dose subcutaneous heparin (UFH 5000U BD/TDS) or LMWH for hospitalised patients, post-surgical patients, and those on prolonged bedrest
  • Key principle: Prophylaxis should be included in all standard hospital admission orders unless specifically contraindicated - starting early is essential as it is ineffective once a clot begins to form

Complications

  • Chronic thromboembolic pulmonary hypertension (CTEPH) - incomplete clot resolution → progressive pulmonary hypertension (treated with surgical pulmonary endarterectomy)
  • Post-PE syndrome - dyspnoea and functional limitation persisting after acute PE
  • Recurrent VTE - especially in unprovoked PE without long-term anticoagulation
  • Right heart failure - from untreated or massive PE
(Rosen's Emergency Medicine 10e, pp. 1202-1210; Textbook of Family Medicine 9e, pp. 329-330)
This is a shared conversation. Sign in to Orris to start your own chat.